ABL1 and acute lymphoblastic leukemia: Characterized by the t(9;22)(q34.1;q11.2) translocation (3, 4), Ph+ B-ALL cells express the aberrantly activated tyrosine kinase (TK) fusion protein BCR-ABL1 that drives signaling pathways promoting cell proliferation and survival (5).